Category Archives: – Policy

The NIH has turned into a source of welfare for bloated universities

September 12, 2017- Science reports, “President Donald Trump’s administration has brought a long-simmering debate over how the U.S. government supports university research

Posted in - Opinion, Congress, NIH | 1 Comment

Avoid ER’s attached to tertiary care hospitals

August 17, 2017- by Steven E. Greer, MD

Posted in - Opinion, - Policy, CMS, Emergency medicine | Leave a comment

CDER Director Janet Woodcock on new drug safety strategies

November 16, 2010- by Steven E. Greer, MD We interviewed Dr. Janet Woodcock, long-time Director of CDER, the FDA center responsible

Posted in - Pharma, FDA | Leave a comment

How to establish a face transplant team

March 3,  2015- Interviewed by Steven E. Greer,  MD In Part 2 of our interview with Eduardo Rodriguez, MD, DDS, Chairman of Plastic Surgery at

Posted in - Policy, NYU, Plastic surgery | Leave a comment

A disease called ‘childhood’

March 31, 2013- by Dr. Allen Frances Do 1 in 5 NYC preteens really suffer a mental woe? A psychiatry expert argues we’re overdiagnosing —

Posted in - Pharma, - Policy, Neurology, Pediatrics, Psychology Psychiatry | Leave a comment

How ADHD became such a prevalent condition

October 7, 2009- interviewed by Steven E. Greer Authors of “ADHD: medicating children”, Rick Mayes and Catherine Bagwell, discuss the history of ADHD

Posted in - Pharma, - Reviews, books, devices, Congress, Neurology, Neurosurgery, Pediatrics, Primary care medicine, Psychology Psychiatry | Leave a comment

The new CDC guidelines for prescribing opioid pain pills

June 1, 2016- Interviewed by Steven E. Greer, MD Pain pill prescriptions have quadrupled since the 1990’s as drug companies stepped up marketing and funded

Posted in - JAMA, - NEJM, - Pharma, CDC, Emergency medicine, General surgery, Oncology, Psychology Psychiatry, Rehab, Spine surgery, Sports medicine | Leave a comment

The 23andMe home genetics test kit controversy

December 19, 2013- Interviewed by Steven E. Greer,  MD

Posted in Columbia, FDA, Genetics, NIH, Oncology, Psychology Psychiatry | Leave a comment

Google wants your DNA now (Not just with 23andMe)

Opinion December 17, 2013- By Steven E. Greer, MD The Wall Street Journal published an article explaining how the pharmaceutical industry data mines

Posted in - Opinion, - Policy, FDA, Genetics | Leave a comment

2017 is the Year of the Woman

November 19, 2017- by Steven E. Greer, MD I am actually surprised at the level of controversy that the Senator Al Franken groping picture has created.

Posted in - Opinion, - Policy, Congress | Leave a comment

Changes in plastic surgery training programs

March 3, 2015- Interviewed by Steven E. Greer, MD In Part 1 of our interview with the new Chairman of Plastic Surgery at NYU, Eduardo Rodriguez,

Posted in - Policy, NYU, Plastic surgery | Leave a comment

The Deans of Johns Hopkins and Miami discuss ACO’s

February 28, 2011- By Steven E Greer, MD Dean Miller of Johns Hopkins and Dean Goldschmidt of Miami discuss accountable care organizations,

Posted in - Policy, CMS, Johns Hopkins | Leave a comment

Interview with the CEO of Neovasc, Alexei Marko

Posted in - Medical Devices, Cardiology, FDA | Leave a comment

This could be the best interview ever aired on Fox Business

August 15, 2017- by Steven E. Greer, MD Martin Shkreli was on Fox Business today, and the set seemed familiar. Ironically, I was in this same

Posted in - Biotech, - Generics, - Medical Devices, - Opinion, - Pharma, - Policy | Leave a comment

Is Vitamin-D deficiency overdiagnosed?

November 8, 2016- Interviewed by Steven E. Greer, MD We interviewed JoAnn E. Manson, MD, DrPH, Chief, Division of Preventive Medicine,  Brigham

Posted in - NEJM, - Policy, CDC, Diabetes and endocrinology, FDA, Harvard, Primary care medicine | Leave a comment

An emerging safety problem for TAVR patients

March 16, 2017- produced and interviewed by Steven E. Greer, MD We interviewed William O’Neill, MD, one of the first to implant a Transcatheter Aortic Valve Replacement (TAVR) valve. The products have been approved by the FDA for several years, … Continue reading

Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA | Leave a comment

Review: Walk-in urgent care centers are the way to go

January 6, 2015- by Steven E. Greer, MD A patient asked for my help yesterday with a sinus infection that was lingering. I referred him to

Posted in - Opinion, - Policy, - Reviews, books, devices, CMS, Emergency medicine, Pediatrics, Primary care medicine | Leave a comment

Early stoppage of clinical trials

April 16, 2009– Dr. Guyatt explained in a previous post why early stoppage of clinical trials results

Posted in Cardiac surgery, FDA, McMaster University | Leave a comment

Trump made a big mistake wading into the quagmire of healthcare

Is President Obama foreseeing the future here and having a laugh? May 7, 2017- Opinion by Steven E. Greer, MD I watched Face the Nation and the news coverage of Friday town hall meetings. Mick Mulvaney was

Posted in - Opinion, CMS, Congress | Leave a comment

Insurance companies are not paying for Repatha and Praluent

March 8, 2017- Interviewed by Steven E. Greer, MD We interviewed cardiologist William O’Neill, MD about his personal need for the cholesterol-lowering, large-molecule, antibody drug from Amgen, branded as Repatha. Despite

Posted in - Biotech, - Pharma, - Policy, Cardiac surgery, Cardiology, Henry Ford, Primary care medicine | 1 Comment